Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

Amgen sets premium price for Blincyto

Leukaemia drug becomes one of the most expensive pharma products on the market

- PMLiVE

Industry welcomes UK’s £6bn science strategy

It will provide funding for projects including a big data collaboration and an ageing-focused innovation centre

- PMLiVE

AZ’s Lynparza cleared for ovarian cancer in Europe

Comes three years after company ditched drug due to poor trial results

- PMLiVE

GCI Health promotes Becky Lauer

She becomes executive VP

- PMLiVE

Data transparency in Europe

Will 2015 usher in a new era?

Xellia forms scientific advisory board

Will further progress on innovative anti-infectives

- PMLiVE

First biosimilar Humira launches in India

AbbVie to face competition for world’s biggest-selling drug

- PMLiVE

Private sector on rise in England’s NHS, says BMJ

One-third of NHS contracts have gone to private providers since healthcare reforms

- PMLiVE

UCB’s $1.53bn generics sale falls through

Advent and Avista Capita back away from bid to acquire Kremers Urban due to unanticipated conflict in timing

- PMLiVE

FDA approves Ipsen drug to treat rare tumours

Green light for Somatuline Depot in cancer of the neuroendocrine system

- PMLiVE

Novartis’ acromegaly therapy cleared by FDA

Signifor LAR shows superior efficiency to older treatments

- PMLiVE

NICE recommends Pradaxa in blood clot indication

Boehringer drug backed to treat and prevent deep vein thrombosis and pulmonary embolism

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links